Miriam researcher helps develop global hepatitis C recommendations for injection-drug users

July 28 is World Hepatitis Day

2013-07-26

(Press-News.org) (PROVIDENCE, R.I.) – A Miriam Hospital researcher has joined forces with international colleagues to call for new strategies to better manage and improve assessment and treatment for hepatitis C (HCV) infection in individuals who inject drugs.

Lynn E. Taylor, M.D., an HIV specialist focusing on HIV and viral hepatitis coinfection at The Miriam Hospital, was the only American physician invited to join the expert international panel that issued these first-of-its-kind recommendations. They were published online yesterday by the journal Clinical Infectious Diseases, just ahead of World Hepatitis Day on July 28.

The recommendations are part of a supplement entitled "Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward," developed in collaboration with the International Network on Hepatitis Care in Substance Users.

"In well-resourced parts of the world, most hepatitis C exists among people who currently inject drugs and those who have injected drugs in the past. However, treatment access and uptake among this population remains low – even though we increasingly have effective treatments for hepatitis C, which is a curable disease," said Taylor.

"Research supporting our recommendations – the first international set ever released for treating hepatitis C in people who inject drugs – demonstrates that treatment can be successful when barriers to care are addressed within a supportive environment," she added. "In fact, the burden of liver disease worldwide could be dramatically reduced by increasing treatment for hepatitis C infection among people who inject drugs, by preventing forward transmission."

An estimated five million people in the U.S. have chronic HCV infection, a liver disease that may result in long-term health problems, including liver scarring, liver failure and liver cancer. According to the Centers for Disease Control and Prevention, approximately 12,000 people die every year from HCV-related liver disease.

Until recently, HCV treatment guidelines excluded people who inject drugs, due to concerns about poor adherence, adverse events and re-infection. However, successful HCV treatment studies among this population have challenged this paradigm. The new international guidelines present evidence-based recommendations for treating HCV among individuals who inject drugs with appropriate evaluation and support. Taylor is also lead author on a separate paper, appearing in the same supplement of Clinical Infectious Diseases, which focuses on the need for improved HCV care of another subset of the HCV-infected population: those who inject drugs and are also infected with HIV.

Chronic HCV infection has become a leading cause of non-AIDS related illness and death among individuals infected with HIV. Due to overlapping routes of transmission, dual infection is common: in the United States, 30 percent of HIV-infected people have chronic HCV, which is spread via contaminated blood, often through injection drug use. However, newer research suggests it may also be transmitted sexually among HIV-infected men who have sex with other men.

"HIV-infected individuals contending with injection drug use are the most likely to be affected by HCV, but the least likely to have access to treatment for HCV," said Taylor. "They should have equal and universal access to HIV/AIDS, HCV and addiction prevention, care and treatment."

She says essential but basic steps include improving prevention and screening for both infections and engaging co-infected individuals who inject drugs in HIV and HCV care early after diagnoses.

"The benefits of therapeutic advances in HCV will be limited for this group until barriers such as cost and access are overcome," she added. "Even with HCV cure rates approaching 100 percent with newer medications, effectiveness at population level will require expanding HCV therapy on large scale. These recommendations are an important step towards the goal of elimination of hepatitis C."

Taylor is also director of the HIV/Viral Hepatitis Program at The Miriam Hospital and an assistant professor of medicine at The Warren Alpert Medical School of Brown University.

### About The Miriam Hospital The Miriam Hospital is a 247-bed, not-for-profit teaching hospital affiliated with The Warren Alpert Medical School of Brown University. It offers expertise in cardiology, oncology, orthopedics, men's health, and minimally invasive surgery and is home to the state's first Joint Commission-certified Stroke Center and robotic surgery program. The hospital, which received more than $23 million in external research funding last year, is nationally known for its HIV/AIDS and behavioral and preventive medicine research, including weight control, physical activity and smoking cessation. The Miriam Hospital has been awarded Magnet Recognition for Excellence in Nursing Services four times and is a founding member of the Lifespan health system. Follow us on Facebook and on Twitter (@MiriamHospital).

ELSE PRESS RELEASES FROM THIS DATE:

UI researchers help answer long-standing question about Van Allen radiation belts

2013-07-26

Two University of Iowa researchers and their colleagues have advanced scientists' knowledge of the Earth's Van Allen radiation belts by answering a long-standing question about the belts. Craig Kletzing and William Kurth of the UI Department of Physics and Astronomy note that since 1958 when UI space physicist James Van Allen discovered the doughnut-shaped bands of intense radiation encircling the Earth, scientists have wondered just how and where electrons trapped within the belts get their ultra-high energies. In a paper published in the July 25 issue of the online ...

Princeton release: Princeton researcher digs into the contested peanut-allergy epidemic

2013-07-26

The path of the peanut from a snack staple to the object of bans at schools, day care centers and beyond offers important insights into how and why a rare, life-threatening food allergy can prompt far-reaching societal change, according to a Princeton University researcher. Before 1980, peanut allergies were rarely mentioned in medical literature or the media, said Miranda Waggoner, a postdoctoral researcher at the Office of Population Research in the Woodrow Wilson School of Public and International Affairs. Her article on the subject, "Parsing the peanut panic: The ...

Bacterial blockade

2013-07-26

For decades, doctors have understood that microbes in the human gut can influence how certain drugs work in the body – by either activating or inactivating specific compounds, but questions have long remained about exactly how the process works. Harvard scientists are now beginning to provide those answers. In a July 19th paper published in Science, Peter Turnbaugh, a Bauer Fellow at Harvard's Faculty of Arts and Sciences (FAS) Center for Systems Biology, and Henry Haiser, a postdoctoral fellow, identify a pair of genes which appear to be responsible for allowing ...

NASA's Hubble: Galaxies, comets, and stars! Oh my!

2013-07-26

Approaching the sun, Comet ISON floats against a seemingly infinite backdrop of numerous galaxies and a handful of foreground stars. The icy visitor, with its long gossamer tail, appears to be swimming like a tadpole through a deep pond of celestial wonders. In reality, the comet is much, much closer. The nearest star to the sun is over 60,000 times farther away, and the nearest large galaxy to the Milky Way is over thirty billion times more distant. These vast dimensions are lost in this deep space Hubble exposure that visually combines our view of the universe from ...

NASA's Van Allen Probes discover particle accelerator in the heart of Earth's radiation belts

2013-07-26

Scientists have discovered a massive particle accelerator in the heart of one of the harshest regions of near-Earth space, a region of super-energetic, charged particles surrounding the globe called the Van Allen radiation belts. Scientists knew that something in space accelerated particles in the radiation belts to more than 99 percent the speed of light but they didn't know what that something was. New results from NASA's Van Allen Probes now show that the acceleration energy comes from within the belts themselves. Particles inside the belts are sped up by local kicks ...

NASA's IRIS telescope offers first glimpse of sun's mysterious atmosphere

2013-07-26

The moment when a telescope first opens its doors represents the culmination of years of work and planning -- while simultaneously laying the groundwork for a wealth of research and answers yet to come. It is a moment of excitement and perhaps even a little uncertainty. On July 17, 2013, the international team of scientists and engineers who supported and built NASA's Interface Region Imaging Spectrograph, or IRIS, all lived through that moment. As the spacecraft orbited around Earth, the door of the telescope opened to view the mysterious lowest layers of the sun's atmosphere ...

A faster vessel for charting the brain

2013-07-26

Princeton University researchers have created "souped up" versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication. Reported July 18 in the journal Nature Communications, the enhanced proteins developed at Princeton respond more quickly to changes in neuron activity, and can be customized to react to different, faster rates of neuron activity. Together, these characteristics would give scientists a more precise and comprehensive view of neuron activity. The researchers ...

Scientists identify key fungal species that help explain mysteries of white nose syndrome

2013-07-26

MADISON, Wis., July 25, 2013 – U.S. Forest Service researchers have identified what may be a key to unraveling some of the mysteries of White Nose Syndrome: the closest known non-disease causing relatives of the fungus that causes WNS. These fungi, many of them still without formal Latin names, live in bat hibernation sites and even directly on bats, but they do not cause the devastating disease that has killed millions of bats in the eastern United States. Researchers hope to use these fungi to understand why one fungus can be deadly to bats while its close relatives are ...

NASA mission involving CU discovers particle accelerator in heart of Van Allen radiation belts

2013-07-26

Using data from a NASA satellite, a team of scientists led by the Los Alamos National Laboratory in New Mexico and involving the University of Colorado Boulder have discovered a massive particle accelerator in the heart of one of the harshest regions of near-Earth space, a region of super-energetic, charged particles surrounding the globe known as the Van Allen radiation belts. The new results from NASA's Van Allen Probes mission show the acceleration energy is in the belts themselves. Local bumps of energy kick particles inside the belts to ever-faster speeds, much like ...

Educators explore innovative 'theater' as a way to help students learn physics

2013-07-26

In a newly released study, education researchers report that personifying energy allowed students to grapple with difficult ideas about how energy works. Contrasted with more traditional lectures and graphs, this innovative instructional technique may be useful for teaching about other ideas in physical science, which commonly deals with things that change form over time. Energy is a very important concept across many fields of science, and is a key focus of the new national science standards. Energy is also a central player in several global issues, such as climate ...

THE LANCET DIABETES & ENDOCRINOLOGY: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

Following a 2005 policy, episiotomy rates have reduced in France without an overall increase in anal sphincter injuries during labor, with more research needed to confirm the safest rate of episiotomi

Miriam researcher helps develop global hepatitis C recommendations for injection-drug users

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: